EU PAL-COPD at EAPC 2025 Congress in Helsinki

The EU PAL-COPD project was proudly represented at the 19th World Congress of the European Association for Palliative Care (EAPC), held from 29–31 May 2025 in Helsinki, Finland.

EU PAL-COPD clinical trial now registered

We are pleased to announce that the EU PAL-COPD clinical trial has been officially registered on the ISRCTN registry. This registration marks a key milestone in our effort to evaluate and adapt the ICLEAR palliative care intervention for people living with advanced COPD.

EU PAL-COPD consortium gathers in Brussels to align on clinical trial launch

Last week, the EU PAL-COPD consortium convened in Brussels for a three-day consortium meeting hosted by Vrije Universiteit Brussel (VUB). Held from 12–14 May 2025, the meeting brought together researchers, clinicians and project managers from across the consortium’s 13 partner institutions to review progress, align on upcoming activities and deliver hands-on training to support the upcoming trial phase.

EU PAL-COPD partners to present key findings at EAPC 2025 Congress

We are excited to announce that our partners from the International Observatory on End of Life Care, Lancaster University (ULANC) and Vrije Universiteit Brussel (VUB) will be presenting the project findings at the 19th World Congress of the European Association for Palliative Care (EAPC) 2025, taking place on May 29–31 in Helsinki, Finland.

EU PAL-COPD Consortium its first Supervisory Board meeting

Last week, the EU PAL-COPD consortium convened virtually for its first Supervisory Board meeting. Held on 27 January, this meeting provided an excellent opportunity to review the significant progress made during the first year of the EU PAL-COPD project and to strategise for the upcoming steps toward the randomised controlled trial of the ICLEAR-EU intervention.